| |
| |
|
| Insider
Information: |
Schleifer Leonard S |
| Relationship: |
Bd. Co-Chair, Presiden... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
466,877 |
|
|
Indirect Shares
|
228,469 |
|
|
| Direct
Value |
$468,254,287 |
|
|
|
Indirect Value
|
$229,142,984 |
|
|
| Total
Shares |
695,346 |
|
|
| Total
Value |
$697,397,271 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Bd. Co-Chair, Presiden... |
2024-05-17 |
466,877 |
2024-05-17 |
228,469 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
89 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
Chief Exec Officer & President |
• • • |
2008-09-29 |
4 |
OE |
$7.41 |
$541,004 |
D/D |
73,010 |
144,720 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2015-01-02 |
4 |
AS |
$408.64 |
$615,867 |
I/I |
(1,500) |
0 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2013-03-07 |
4 |
AS |
$175.13 |
$618,909 |
D/D |
(3,534) |
150,404 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2013-03-19 |
4 |
AS |
$175.02 |
$639,698 |
D/D |
(3,655) |
142,087 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2013-03-13 |
4 |
AS |
$175.01 |
$815,897 |
D/D |
(4,662) |
145,742 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
officerTitle |
• • • |
2005-12-27 |
4 |
OE |
$12.75 |
$1,020,000 |
D/D |
80,000 |
192,263 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chief Exec Officer & President |
• • • |
2008-09-29 |
4 |
D |
$23.28 |
$1,030,675 |
D/D |
(44,273) |
100,447 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
officerTitle |
• • • |
2005-12-27 |
4 |
D |
$15.67 |
$1,100,912 |
D/D |
(70,256) |
122,007 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chief Exec Officer & President |
• • • |
2006-11-07 |
4 |
AS |
$23.00 |
$1,248,296 |
D/D |
(53,986) |
61,665 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
CEO and President |
• • • |
2009-12-15 |
4 |
OE |
$8.77 |
$1,315,500 |
D/D |
150,000 |
282,058 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chief Exec Officer & President |
• • • |
2006-11-06 |
4 |
OE |
$8.63 |
$1,317,699 |
D/D |
150,000 |
194,679 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
CEO & President |
• • – |
2013-09-09 |
4 |
AS |
$275.04 |
$1,377,332 |
I/I |
(5,000) |
0 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2014-11-11 |
4 |
AS |
$400.00 |
$1,397,200 |
D/D |
(3,493) |
84,411 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chief Exec Officer & President |
• • – |
2003-09-17 |
4 |
OE |
$14.75 |
$1,843,750 |
D/D |
125,000 |
200,095 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2022-04-06 |
4 |
AS |
$710.04 |
$1,883,736 |
I/I |
(2,653) |
11,178 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2022-03-31 |
4 |
AS |
$710.01 |
$2,049,089 |
I/I |
(2,886) |
18,292 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
CEO and President |
• • • |
2009-12-15 |
4 |
D |
$19.89 |
$2,054,498 |
D/D |
(103,293) |
178,765 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2013-09-18 |
4 |
OE |
$9.49 |
$2,072,512 |
D/D |
218,389 |
260,476 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chief Exec Officer & President |
• • – |
2003-09-17 |
4 |
D |
$20.95 |
$2,118,862 |
D/D |
(101,139) |
98,956 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chief Exec Officer & President |
• • • |
2006-11-06 |
4 |
D |
$22.25 |
$2,136,312 |
D/D |
(96,014) |
115,651 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2013-10-02 |
4 |
AS |
$312.44 |
$2,875,253 |
D/D |
(9,162) |
42,087 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2015-09-02 |
4 |
OE |
$402.69 |
$2,909,838 |
D/D |
7,226 |
49,313 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2022-04-05 |
4 |
AS |
$710.05 |
$3,167,533 |
I/I |
(4,461) |
13,831 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2013-10-01 |
4 |
OE |
$111.01 |
$3,249,929 |
D/D |
29,276 |
52,485 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2015-09-02 |
4 |
D |
$506.37 |
$3,294,950 |
D/D |
(6,507) |
42,806 |
0 |
- |
|
89 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
